F. Hoffmann-La Roche Ltd - Company Profile
Powered by 
All the data and insights you need on F. Hoffmann-La Roche Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date F. Hoffmann-La Roche Ltd Strategy Report
- Understand F. Hoffmann-La Roche Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreF. Hoffmann-La Roche Marketed Drugs
Understand F. Hoffmann-La Roche Ltd’s commercialized product portfolio to stay one step ahead of the market.
A sample of F. Hoffmann-La Roche Marketed Drugs data
| Drug Name | Generic Name | Brand Name | Company Name | Therapy Area | Indication | Development Stage | Drug Geography |
|---|---|---|---|---|---|---|---|
| Lorem | Lorem | Lorem | Lorem | Lorem | Lorem | Planned | Lorem |
| alphaprodine | alphaprodine [INN] | Nisentil | Hoffmann-La Roche Inc | Central Nervous System | Dental Pain (Toothache/Tooth Pain) | Withdrawn | United States |
| (hyaluronidase (recombinant human) + pertuzumab + trastuzumab) | (hyaluronidase-zzxf (recombinant human) + pertuzumab + trastuzumab) | Perjeta + Herceptin | F. Hoffmann-La Roche Ltd | Oncology | Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) | Marketed | China |
| (hyaluronidase (recombinant human) + pertuzumab + trastuzumab) | (hyaluronidase-zzxf (recombinant human) + pertuzumab + trastuzumab) | Phesgo | Roche Products Pty Ltd | Oncology | Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) | Marketed | Australia |
Feature
Marketed Drugs is an integrated platform that provides interactive, comprehensive, and analytical competitive intelligence of Marketed Pharmaceutical Drug information.
Benefit
Marketed Drugs covers an extensive number of therapy areas and indications across 23 countries. Marketed Drug profiles provide a comprehensive breakdown of information spanning across Drug Details, Marketed Drug Overview (Lifecycle Management, Safety Details and Efficacy Details), Marketing Information (Regulatory Information), Clinical Trials, Sales and Consensus Forecast and Net Present Value.
Keep up-to-date on new Pipeline drug developments and market approvals. Competitive analysis of Marketed drugs.
Value
Marketed Drug data is used prominently to generate a range of premium analytical reports offering unique insight. Seamless integration makes in depth investigation of drugs extremely simple.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer